ERBB2 and neoplasm: In addition to ICB, TLS formation correlates with responses to neoadjuvant chemotherapy and targeted HER2 therapy37,38, mirroring our G12Ci data and indicating that TLS may have unexpected roles in tumour cell-targeted therapies.